Symbol="JANX"
AssetType="Common Stock"
Name="Janux Therapeutics Inc"
Description="Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology to treat cancer patients. The company is headquartered in La Jolla, California."
CIK="1817713"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11099 TORREY PINES PARK ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="507988000"
EBITDA="-75741000"
PERatio="None"
PEGRatio="None"
BookValue="7.15"
DividendPerShare="0"
DividendYield="0"
EPS="-1.61"
RevenuePerShareTTM="0.186"
ProfitMargin="0"
OperatingMarginTTM="-9.96"
ReturnOnAssetsTTM="-0.133"
ReturnOnEquityTTM="-0.211"
RevenueTTM="7763000"
GrossProfitTTM="-44829000"
DilutedEPSTTM="-1.61"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.553"
AnalystTargetPrice="27.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="71.67"
PriceToBookRatio="1.697"
EVToRevenue="33.56"
EVToEBITDA="-4.025"
Beta="1.528"
num_52WeekHigh="23.64"
num_52WeekLow="10"
num_50DayMovingAverage="12.27"
num_200DayMovingAverage="14.29"
SharesOutstanding="46138800"
DividendDate="None"
ExDividendDate="None"
symbol="JANX"
open="11.17"
high="11.18"
low="10.82"
price="11.01"
volume="56053.00"
latest_trading_day="2023-08-25"
previous_close="11.13"
change="-0.12"
change_percent="-1.0782%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="68"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="32"
Volume_recent_avg="118823"
Change_recent_avg="-0.03"
Delta_recent_avg="0.9"
Variance_recent_avg="0.45"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_negative_thumbnail_id_2="1096"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0129.jpeg"
image_neutral_thumbnail_id_1="593"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="654"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_positive_thumbnail_id_2="599"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
